Physician profile
Robert M Kosinski
NPI 1780655068
$25,747.99
in general payments reported to CMS, 2019-2025
56 companies · $4,956 in 2025
The $4,956 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $660 · 2020: $3,596 · 2021: $3,146 · 2022: $3,703 · 2023: $4,185 · 2024: $5,500 · 2025: $4,956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $1,143 · Education: $61.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,436.87 |
| Travel and Lodging | $1,142.83 |
| Education | $61.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $5,086.45 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $3,499.03 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,954.02 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Inspire Medical Systems, INC. | $1,448.14 | 2023-2025 | Inspire |
| Mylan Specialty L.P. | $1,283.07 | 2019-2024 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $1,278.02 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Insmed, INC. | $1,034.90 | 2020-2025 | Arikayce, Brinsupri |
| Takeda Pharmaceuticals U.S.A., INC. | $975.02 | 2021-2025 | Glassia, Cuvitru, Hyqvia |
| Genzyme Corporation | $731.85 | 2019-2025 | |
| Grifols USA, LLC | $652.73 | 2020-2025 | Prolastin-C Liquid |
| United Therapeutics Corporation | $646.71 | 2022-2025 | Tyvaso, Tyvaso |
| Regeneron Healthcare Solutions, INC. | $497.54 | 2019-2024 | Dupixent |
| Aop Health US, LLC | $474.19 | 2025 | Rapiblyk |
| Mallinckrodt Hospital Products INC. | $407.71 | 2021-2025 | Acthar, Terlivaz |
| Ani Pharmaceuticals, INC. | $400.20 | 2023-2025 | Purified Cortrophin Gel |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $392.77 | 2022-2025 | Smartvest |
| Novartis Pharmaceuticals Corporation | $383.92 | 2020-2025 | |
| Jazz Pharmaceuticals INC. | $377.58 | 2019-2024 | Xywav |
| Amgen INC. | $362.34 | 2021-2025 | Tezspire, Tavneos |
| Philips North America LLC | $343.12 | 2021-2024 | (Ak6) Vest Therapy |
| Inogen, INC. | $317.87 | 2022-2024 | Inogen |
| Pulmonx Corporation | $310.42 | 2023-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Fisher & Paykel Healthcare INC | $263.35 | 2020-2024 | Fisher & Paykel Healthcare |
| Viatris Specialty LLC | $256.96 | 2025 | Yupelri |
| Axsome Therapeutics, INC. | $239.92 | 2022-2025 | Sunosi |
| Merck Sharp & Dohme LLC | $229.34 | 2019-2025 | Winrevair, Keytruda |
| Harmony Biosciences LLC | $214.38 | 2020-2025 | |
| Ethicon INC. | $191.67 | 2024 | Monarch Platform |
| Genentech USA, INC. | $176.02 | 2022-2025 | Xolair, Tecentriq |
| Baxter Healthcare | $122.68 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Portola Pharmaceuticals, LLC | $98.13 | 2019-2020 | |
| Shionogi INC | $95.19 | 2023-2025 | Fetroja |
| Alexion Pharmaceuticals, INC. | $92.43 | 2020-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $83.97 | 2024-2025 | Lumryz |
| Gilead Sciences, INC. | $80.28 | 2021-2024 | Veklury |
| Allergan, INC. | $76.42 | 2020 | |
| Idorsia Pharmaceuticals US INC | $69.79 | 2022-2023 | Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $63.02 | 2021-2023 | |
| Vapotherm INC | $61.39 | 2021 | |
| Lilly USA, LLC | $58.26 | 2025 | Zepbound |
| Abbvie INC. | $53.84 | 2023-2024 | |
| Covidien LP | $44.58 | 2019 | |
| Paratek Pharmaceuticals, INC. | $40.20 | 2022 | |
| Novo Nordisk INC | $37.14 | 2021 | |
| Resmed Corp | $34.41 | 2023 | |
| Circassia INC. | $28.28 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $27.48 | 2021-2022 | |
| Ambu INC. | $26.78 | 2023 | |
| Vifor Pharma, INC. | $20.38 | 2025 | Zemaira |
| Eisai INC. | $17.44 | 2020 | |
| Boston Scientific Corporation | $17.08 | 2023 | Exalt Model D |
| Advanced Respiratory, INC | $15.99 | 2021 | |
| Csl Behring | $14.54 | 2025 | Kcentra |
| Shire North American Group INC | $14.12 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.66 | 2021 | |
| Pfizer INC. | $12.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kosinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.